Through our core technical capabilities in modern traditional Chinese medicine (TCM) and advanced controlled-release formulations, Baheal Medical has established a sophisticated R&D and production system for both TCM and chemical medicines. We have successfully launched a variety of innovative products with proprietary intellectual property rights, and consistently drive forward technological development and production for upstream medical innovations.
Shanghai - Natural Medicine R&D and Transformation PlatformQingdao - Chemical Drug R&D and Transformation PlatformLangfang - High-end Manufacturing Industrialization Base
Adhering to the philosophy of diagnosable diseases, controllable quality and demonstrable efficacy, it has built a natural medicine R&D and manufacturing platform covering medicinal herb cultivation and processing, active ingredient extraction, formulation development and large-scale production.

24600㎡
Land Area

2.59Billion tablets
Annual production capacity

As a chemical drug R&D and transformation platform, it focuses on the R&D and commercial production of advanced formulation technologies such as osmotic pumps and pellet coating matrix tablets.
· Co-production and sales in China and the USA, with multiple products simultaneously registered and sold in both markets.

cGMP Certification by FDA
"Zero Defect", Co-production and sales in China and the USA

85600㎡
Land Area

6.5Billion tablets
Annual production capacity

As a high-end radiotherapy device manufacturing platform that integrates R&D, production, testing, maintenance and training, to achieve “Made in China, Delivered Globally.”

9739㎡
Land Area

100units
Annual production capacity




